GARDNER MARK A

DGX

GARDNER MARK A serves as SVP of Molecular Gen & Oncol at Quest Diagnostics Incorporated (DGX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$66.4K

Net Position

Net Seller

$66.4K

Companies Traded

DGX

Active Period

Sep 2023 – Sep 2024

3 total trades

Most Recent

Sell DGX

Sep 24, 2024 · $18.7K

GARDNER MARK A's Insider Trading at Quest Diagnostics Incorporated (DGX)

Buys

0 · $0.00

Sells

3 · $66.4K

Total Shares Bought

Total Shares Sold

498

DGX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Sep 24, 2024↗	Sell	120	$155.70	$18.7K
Feb 28, 2024↗	Sell	262	$126.36	$33.1K
Sep 25, 2023↗	Sell	116	$126.22	$14.6K

Related Insiders

PREVOZNIK MICHAEL E

officer: SVP & General Counsel

DGXSell · Mar 5, 2026

Catherine T. Doherty

officer: EVP, Regional Businesses

DGXSell · Mar 5, 2026

Patrick Plewman

officer: SVP for Diagnostic Services

DGXSell · Mar 5, 2026

KUPPUSAMY KARTHIK

officer: SVP, Clinical Solutions

DGXSell · Mar 4, 2026

J. E. Davis

director, officer: CEO and President

DGXSell · Mar 2, 2026

Catherine T. Doherty

EVP, Regional Businesses

DGXSell · Feb 19, 2026

Patrick Plewman

SVP for Diagnostic Services

DGXSell · Feb 19, 2026

PREVOZNIK MICHAEL E

SVP & General Counsel

DGXSell · Feb 19, 2026

Explore More Insider Trading Data

DGX Insider Trading Activity

View all insider trades at Quest Diagnostics Incorporated

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity